Department of Radiology, the Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):1135-1145. doi: 10.26355/eurrev_202101_24684.
To explore the different clinical and CT features distinguishing COVID-19 from H1N1 influenza pneumonia.
We compared two independent cohorts of COVID-19 pneumonia (n=405) and H1N1 influenza pneumonia (n=78), retrospectively. All patients were confirmed by RT-PCR. Four hundred and five cases of COVID-19 pneumonia were confirmed in nine hospitals of Zhejiang province, China from January 21 to February 20, 2020. Seventy-eight cases of H1N1 influenza pneumonia were confirmed in our hospital from January 1, 2017 to February 29, 2020. Their clinical manifestations, laboratory test results, and CT imaging characteristics were compared.
COVID-19 pneumonia patients showed less proportions of underlying diseases, fever and respiratory symptoms than those of H1N1 pneumonia patients (p<0.01). White blood cell count, neutrophilic granulocyte percentage, C-reactive protein, procalcitonin, D-Dimer, and lactate dehydrogenase in H1N1 pneumonia patients were higher than those of COVID-19 pneumonia patients (p<0.05). H1N1 pneumonia was often symmetrically located in the dorsal part of inferior lung lobes, while COVID-19 pneumonia was unusually showed as a peripheral but non-specific lobe distribution. Ground glass opacity was more common in COVID-19 pneumonia and consolidation lesions were more common in H1N1 pneumonia (p<0.01). COVID-19 pneumonia lesions showed a relatively clear margin compared with H1N1 pneumonia. Crazy-paving pattern, thickening vessels, reversed halo sign and early fibrotic lesions were more common in COVID-19 pneumonia than H1N1 pneumonia (p<0.05). Pleural effusion in COVID-19 pneumonia was significantly less common than H1N1 pneumonia (p<0.01).
Compared with H1N1 pneumonia in Zhejiang, China, the clinical manifestations of COVID-19 pneumonia were more concealed with less underlying diseases and slighter respiratory symptoms. The more common CT manifestations of COVID-19 pneumonia included ground-glass opacity with a relatively clear margin, crazy-paving pattern, thickening vessels, reversed halo sign, and early fibrotic lesions, while the less common CT manifestations of COVID-19 pneumonia included consolidation and pleural effusion.
探讨区分 COVID-19 与 H1N1 流感肺炎的不同临床和 CT 特征。
我们回顾性比较了 2020 年 1 月 21 日至 2 月 20 日在中国浙江省 9 家医院确诊的 405 例 COVID-19 肺炎和我院 2017 年 1 月 1 日至 2020 年 2 月 29 日确诊的 78 例 H1N1 流感肺炎的 2 个独立队列。所有患者均通过 RT-PCR 确诊。COVID-19 肺炎患者中,合并基础疾病、发热、呼吸道症状的比例均低于 H1N1 流感肺炎患者(p<0.01)。H1N1 流感肺炎患者白细胞计数、中性粒细胞百分比、C 反应蛋白、降钙素原、D-二聚体、乳酸脱氢酶均高于 COVID-19 肺炎患者(p<0.05)。H1N1 流感肺炎常呈对称分布于下肺背段,而 COVID-19 肺炎则呈外周但非特异性肺叶分布。磨玻璃影在 COVID-19 肺炎中更为常见,实变病变在 H1N1 肺炎中更为常见(p<0.01)。与 H1N1 肺炎相比,COVID-19 肺炎的病变边界相对清晰。COVID-19 肺炎中常见铺路石征、血管增厚、反晕征和早期纤维化病变,而这些在 H1N1 肺炎中则相对少见(p<0.05)。COVID-19 肺炎胸腔积液的发生率明显低于 H1N1 肺炎(p<0.01)。
与中国浙江的 H1N1 肺炎相比,COVID-19 肺炎的临床表现隐匿,合并基础疾病少,呼吸道症状较轻。COVID-19 肺炎更常见的 CT 表现包括磨玻璃影,边界相对清晰,铺路石征、血管增厚、反晕征和早期纤维化病变,而实变和胸腔积液则相对少见。